Sunday, May 24, 2026

How Celltrion’s Herceptin Biosimilar Herzuma Achieved 74% Market Share in Japan: A Game Changer for Cancer Treatment

Celltrion's Herzuma biosimilar captures 74% of Japan's trastuzumab market, enhancing patient access and leveraging favorable policies.

Samsung Display Expands Recruitment in the U.S. to Secure Top Global Talent

Samsung Display hosted a Tech Forum in LA to recruit top talent, emphasizing AI's role in OLED technology and expanding its U.S. outreach.

Tag: political agenda

No posts to display

Top News

- Our Sponsors Ad -

Follow us